Relmada CFO Maged Shenouda acquires $843,140 of common shares
RLMD•CFO buys 200,000 shares in the open market
Relmada Therapeutics CFO Maged Shenouda bought 200,000 common shares in open-market purchases at about $4.20–$4.25 each.
Directly held stake rises to 1,000,000 shares
His directly held stake rose to 1,000,000 common shares following the transactions.
